Cargando…

Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids

The amphipathic α-helical antimicrobial peptide MSI-103 (aka KIA21) can form stable transmembrane pores when the bilayer takes on a positive spontaneous curvature, e.g. by the addition of lyso-lipids. Solid-state (31)P- and (15)N-NMR demonstrated an enrichment of lyso-lipids in these toroidal wormho...

Descripción completa

Detalles Bibliográficos
Autores principales: Strandberg, Erik, Bentz, David, Wadhwani, Parvesh, Ulrich, Anne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070102/
https://www.ncbi.nlm.nih.gov/pubmed/32170095
http://dx.doi.org/10.1038/s41598-020-61526-w
_version_ 1783505909084848128
author Strandberg, Erik
Bentz, David
Wadhwani, Parvesh
Ulrich, Anne S.
author_facet Strandberg, Erik
Bentz, David
Wadhwani, Parvesh
Ulrich, Anne S.
author_sort Strandberg, Erik
collection PubMed
description The amphipathic α-helical antimicrobial peptide MSI-103 (aka KIA21) can form stable transmembrane pores when the bilayer takes on a positive spontaneous curvature, e.g. by the addition of lyso-lipids. Solid-state (31)P- and (15)N-NMR demonstrated an enrichment of lyso-lipids in these toroidal wormholes. Anionic lyso-lipids provided additional stabilization by electrostatic interactions with the cationic peptides. The remaining lipid matrix did not affect the nature of the pore, as peptides maintained the same orientation independent of lipid charge, and a change in membrane thickness did not considerably affect their tilt angle. Under optimized conditions (i.e. in the presence of lyso-lipids and appropriate bilayer thickness), stable and well-aligned pores could be obtained for solid-state (2)H-NMR analysis. These data revealed for the first time the complete 3D alignment of this representative amphiphilic peptide in fluid membranes, which is compatible with either monomeric helices as constituents, or left-handed supercoiled dimers as building blocks from which the overall toroidal wormhole is assembled.
format Online
Article
Text
id pubmed-7070102
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70701022020-03-22 Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids Strandberg, Erik Bentz, David Wadhwani, Parvesh Ulrich, Anne S. Sci Rep Article The amphipathic α-helical antimicrobial peptide MSI-103 (aka KIA21) can form stable transmembrane pores when the bilayer takes on a positive spontaneous curvature, e.g. by the addition of lyso-lipids. Solid-state (31)P- and (15)N-NMR demonstrated an enrichment of lyso-lipids in these toroidal wormholes. Anionic lyso-lipids provided additional stabilization by electrostatic interactions with the cationic peptides. The remaining lipid matrix did not affect the nature of the pore, as peptides maintained the same orientation independent of lipid charge, and a change in membrane thickness did not considerably affect their tilt angle. Under optimized conditions (i.e. in the presence of lyso-lipids and appropriate bilayer thickness), stable and well-aligned pores could be obtained for solid-state (2)H-NMR analysis. These data revealed for the first time the complete 3D alignment of this representative amphiphilic peptide in fluid membranes, which is compatible with either monomeric helices as constituents, or left-handed supercoiled dimers as building blocks from which the overall toroidal wormhole is assembled. Nature Publishing Group UK 2020-03-13 /pmc/articles/PMC7070102/ /pubmed/32170095 http://dx.doi.org/10.1038/s41598-020-61526-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any xdmedium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Strandberg, Erik
Bentz, David
Wadhwani, Parvesh
Ulrich, Anne S.
Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids
title Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids
title_full Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids
title_fullStr Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids
title_full_unstemmed Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids
title_short Chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids
title_sort chiral supramolecular architecture of stable transmembrane pores formed by an α-helical antibiotic peptide in the presence of lyso-lipids
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070102/
https://www.ncbi.nlm.nih.gov/pubmed/32170095
http://dx.doi.org/10.1038/s41598-020-61526-w
work_keys_str_mv AT strandbergerik chiralsupramoleculararchitectureofstabletransmembraneporesformedbyanahelicalantibioticpeptideinthepresenceoflysolipids
AT bentzdavid chiralsupramoleculararchitectureofstabletransmembraneporesformedbyanahelicalantibioticpeptideinthepresenceoflysolipids
AT wadhwaniparvesh chiralsupramoleculararchitectureofstabletransmembraneporesformedbyanahelicalantibioticpeptideinthepresenceoflysolipids
AT ulrichannes chiralsupramoleculararchitectureofstabletransmembraneporesformedbyanahelicalantibioticpeptideinthepresenceoflysolipids